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Abstract
Background: Missing from the huge literature on women’s attitudes and beliefs concerning specific contraceptive
methods is any detailed quantitative documentation for all major methods in low- and middle-income countries.
The objectives are to provide such a documentation for women living in Matlab (rural Bangladesh), Nairobi slums
and Homa Bay (rural Kenya) and to compare the opinions and beliefs of current, past and never users towards the
three most commonly used methods (oral contraceptives, injectables and implants).
Methods: In each site, 2424 to 2812 married women aged 15–39 years were interviewed on reproduction, fertility
preferences, contraceptive knowledge and use, attitudes and beliefs towards family planning in general and specific
methods. We analysed the data from round one of the prospective cohort study.
Results: While current users typically expressed satisfaction and held more positive beliefs about their method than
past or never users, nevertheless appreciable minorities of current users thought the method might pose serious
damage to health, might impair fertility and was unsafe for prolonged use without taking a break. Larger
proportions, typically between 25% and 50%, associated their method with unpleasant side effects. Past users of
pills and injectables outnumbered current users and their beliefs were similar to those of never users. In all three
sites, about half of past injectable users reported satisfaction with the method and the satisfaction of past implant
users was lower.
Conclusions: High levels of contraceptive use can clearly co-exist with widespread misgivings about methods,
even those that are widely used. Serious concerns about damage to health, long term fertility impairment, and
dangers of prolonged use without taking a break were particularly common in the Kenyan sites and these beliefs
may explain the high levels of discontinuation observed in Kenya and elsewhere in Africa. This documentation of
beliefs provides useful guidance for counselling and informational campaigns. The generally negative views of past
users imply that programmes may need not only to improve individual counselling but also strengthen community
information campaign to change the overall climate of opinion which may have been influenced by dissatisfaction
among past users.
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Plain english summary
In low- and middle-income countries, women’s beliefs
about specific contraceptive methods are not well under-
stood. This study documents the beliefs about eight
contraceptive methods among women living in Matlab
(rural Bangladesh), Nairobi slums and Homa-Bay (rural
Kenya) and compares the opinions of current, past and
never users of the most commonly used methods (oral
contraceptives, injectables and implants). In each site,
we interviewed 2424 to 2812 married women aged 15–
39 years. As expected, we found that current contracep-
tive users were typically satisfied and had more positive
beliefs about their method than past or never users.
Nevertheless, large minorities of current users thought
that their method might cause serious health problems,
impair future childbearing and was unsafe to use for a
long time; higher proportions (25–50%) reported that
their method use caused unpleasant side effects. Past
users of pills and injectables outnumbered current users
and their beliefs were similar to never users. In all three
sites, about half of past injectable users reported satisfac-
tion with the method but the satisfaction of past implant
users was lower. Despite high contraceptive use in these
populations, adverse and inaccurate beliefs about the
major methods persist, particularly in Kenya. This study
provides useful guidance for counselling and informa-
tional campaigns. The generally negative views of past
users imply that programmes may need not only to im-
prove individual counselling but also strengthen com-
munity information campaign to change the overall
climate of opinion which may have been influenced by
dissatisfaction among past users.
Background
Over the past half century, an extensive literature has
been accumulated on women’s attitudes and beliefs con-
cerning contraception in general and specific methods.
The extensive evidence for low- and middle-income
countries (LMICs) falls into four main categories. The
most common category comprises studies that examine
attitudes towards and beliefs about contraception in gen-
eral, with little or no distinction between specific
methods [1–6]. The emphasis in many papers is on
negative perceptions, often labelled as myths and misin-
formation. Commonly reported themes include the be-
lief that use of modern methods will cause long term
infertility, serious health damage, such as cancer and
foetal abnormalities. In some studies, respondents asso-
ciated contraception with promiscuity [2].
The second category concerns specific methods.
Owing to the HIV pandemic, a huge literature on be-
liefs about condoms has been generated, much of
which has been summarised by Maticka-Tyndale [7].
A review of perspectives on intra-uterine devices
(IUDs) identified 14 studies from Africa, Asia and
Latin America [8]. Positive features of this method in-
cluded its high effectiveness and long-acting nature
while commonly expressed concerns were health risks
including cancer, ectopic pregnancy, infertility and
harm to the husband during intercourse. A study in
Kenya found that postpartum women preferred im-
plants over IUDs because of less pain, less infringe-
ment of modesty and preference for a superficial
insertion in the upper arm than in the uterus [9].
The literature on hormonal methods shows the dom-
inant concerns to be side effects such as nausea, diz-
ziness and weight change, menstrual disruption and
infertility [10–12]. In both Mali and Kenya, many
women believed that oral contraceptives accumulate
inside the body, causing infertility or a variety of
diseases [13, 14].
The most influential, though indirect, body of evidence
on views about contraceptive methods is based on self-
reported reasons for non-use or discontinued use of
contraception. The dominant source of data is the Demo-
graphic and Health Surveys (DHSs). The most recent ana-
lysis of reasons for non-use among married women not
wishing to get pregnant found that, in most of the 52
countries studied, 20–33% cited side effects or health con-
cerns. In 21 countries, this category of reason was the
most common [15]. Moreover, in many countries, the ma-
jority of women giving this reason for contraceptive avoid-
ance had previously used a modern method. Thus fear of
side effects (and perhaps concerns about health) is partly
based on personal experience and partly on hearsay evi-
dence from friends or from media [16].
Table 1 Selected Background of Respondents
Characteristics Matlab Nairobi Homa Bay
Educational attainment (%)
Primary or less 30.4 60.4 77.5
Secondary or higher 69.6 39.6 22.5
Current FP method use (%) (1)
No use 40.7 24.6 35.5
Pills 25.4 8.4 2.7
Injectables 17.7 32.4 26.8
Implants 2.2 19.8 17.9
Condoms 5.5 1.7 8.1
Other 8.5 13.2 8.9
Women want no more children (%) 44.8 27.0 29.2
Mean age of women 29.3 29.1 27.9
Mean number of living children 1.9 2.3 3.4
Total Number of Respondents 2605 2812 2424
(1) If more than one method is used, only the most effective method is
included in this table
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Table 2 Percentage of women with specific opinions, amongst those who have heard of methods (Matlab)
Attributes Pills Injectables Implants IUD Condoms Female sterilisation
Access
Easy 97.2 90.4 66.1 69.5 87.1 71.5
Hard 2.2 8.0 24.9 24.1 9.6 23.9
Don’t know/unsure 0.6 1.6 9.0 6.4 3.3 4.6
Effectiveness
Yes 99.3 98.6 97.0 97.3 88.0 97.6
No 0.5 1.0 0.5 0.5 8.3 0.8
Don’t know 0.2 0.4 2.5 2.2 3.7 1.6
Cause health problems
Yes, serious 3.0 7.3 8.3 10.3 3.5 6.7
Yes, not serious 20.5 33.0 15.3 15.1 3.0 8.6
No 69.1 40.2 11.1 8.0 58.6 27.3
Don’t know 7.4 19.5 65.3 66.6 34.9 57.4
Interfere with menstruation
Yes 7.6 56.8 15.7 16.5 – 4.3
No 84.4 21.6 12.9 12.0 – 33.5
Don’t know 8.0 21.6 71.4 71.5 – 62.3
Cause unpleasant side effect
Yes 26.2 37.8 18.7 21.5 7.9 7.7
No 66.1 41.7 12.2 9.0 54.1 30.8
Don’t know 7.7 20.5 69.1 69.5 38.0 61.5
Unsafe to use for a long time
Yes, should take a break 21.2 23.4 20.4 21.2 23.4 –
No, safe for long time 74.3 67.1 52.7 53.7 53.7 –
Don’t know 4.5 9.5 26.9 25.1 22.9 –
Cause infertility
Yes, perhaps 8.8 6.5 4.1 4.1 – –
No 85.2 84.8 74.8 76.2 – –
Don’t know 6.0 8.7 21.1 19.7 – –
FP use among friend, relatives
Most 25.0 17.0 0.7 0.9 1.2 0.8
About half 11.8 14.9 1.3 1.3 0.3 0.7
Few 54.2 52.2 41.2 36.1 31.1 52.3
None 4.2 8.2 28.1 31.8 14.5 21.1
Don’t know 4.8 7.7 28.6 29.9 52.9 25.1
Experiences of friend, relatives (1)
Satisfactory 95.6 89.5 77.2 75.5 82.4 87.5
Unsatisfactory 2.2 5.6 8.6 10.2 3.2 2.0
Mixed/Don’t know 2.2 4.8 14.2 14.3 14.4 10.5
Husband’s approval
Approve 89.4 71.2 19.9 22.0 37.5 14.2
Disapprove 7.5 22.6 64.2 64.4 52.7 70.8
Don’t know 3.1 6.2 15.9 13.6 9.8 15.0
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Reasons for discontinued use is more useful than
reasons for non-use in distinguishing method-specific
concerns. For oral contraceptives, injectables and
IUDs, side effects or health concerns are the most
common reason for stopping use. For condoms, ob-
jections from the husband or desire for a more effect-
ive method are the key reasons while for withdrawal
and periodic abstinence accidental pregnancy domi-
nates [17]. One limitation of this type of evidence is
lack of comparable data for continuing users who
perhaps are equally concerned about side effects or
health risks as discontinued users but persist with use
because of stronger motivation to avoid pregnancy or
for some other reason.
The final main type of studies addresses the character-
istics of contraceptive technology that women judge to
be important. The single largest study of this type in-
volved focus group discussions with 576 women in seven
countries, six of which were LMICs [18]. Widespread
agreement was found on the key importance of effective-
ness and reversibility. Opinions varied by site on the de-
sirability of a quick return to fertility after stopping the
method and of the possibility of clandestine use. Most
women found amenorrhea as a result of hormonal
method use to be disturbing and similar results were
found in Ghana and Nigeria [19, 20]. In a systematic re-
view of contraceptive attributes that women take into ac-
count when choosing a method drawing on studies in
USA and Europe as well as LMICs, ease of use, frequency
of use, return to fertility, and side effects and health con-
cerns were the most commonly mentioned [21].
Conspicuously and surprisingly lacking from the
evidence-base for LMICs is detailed, quantitative docu-
mentation of the beliefs of women concerning all major
methods of contraception. Our study addresses the
omission by presenting descriptive survey data on
method-specific beliefs in three populations. The data
presented here form part of a wider prospective cohort
study whose aims are to advance the understanding of
reasons for unmet need for contraception and measure-
ment of fertility preferences. The detailed rationale and
study protocol may be found elsewhere [22]. In brief, its
conceptual underpinnings posit that adverse method-
specific beliefs constitute one cause of unmet need and
unintended pregnancy, alongside four other factors
(generic hostility to contraception, partner-related fac-
tors, weak or inconsistent fertility preferences and low
perceived risk of pregnancy). The prospective design of
the study will permit assessment of the relative power of
these factors to predict method-specific adoption, con-
tinuation and pregnancy-incidence. Here, however, we
present data from round one with the aim of document-
ing method-specific beliefs and of comparing the beliefs
concerning oral contraceptives, injectables and implants
of current, past and never users.
Methods
The survey was conducted in the icddr,b service area
and the government service area of the Matlab Health
and Demographic Surveillance System (HDSS),
Bangladesh, the Nairobi Urban Health and Demo-
graphic Surveillance System (NUHDSS) in two slums
in Nairobi, Kenya, and Homa Bay County in rural
Western Kenya. Details of the three study population
have been published [22], but, in summary, contra-
ception has been well established in Matlab for de-
cades and the total fertility rate (TFR) is 2.7 [23]. The
population is predominantly Muslim. In Nairobi
slums, the TFR is 3.5 and HIV prevalence is 8% in
the adult population [24, 25]. In the two slums cov-
ered by the NUHDSS, the population is ethnically di-
verse, the majority belong to a Christian faith and
mobility is high. Homa Bay’s population is predomin-
antly rural, Christian and of Luo ethnicity. It has a
high TFR of 5.2, high unmet need for contraception
and a severe HIV epidemic with an infection level in
the adult population of 26% [26]. All married or co-
habiting women aged between 15 and 39 years resid-
ing in the three sites were eligible for the study. We
set a target sample size for each site of 2600. The
sample size was determined to detect a 30% differ-
ence in reproductive outcomes (pregnancy, use and
non-use of contraceptives) at 95% confidence level
and 80% power with an assumption of 10% non-
response rate [27].
Data collection was carried out between August and
December 2016. Respondents were randomly sampled
from eligible female residents from the HDSS
Table 2 Percentage of women with specific opinions, amongst those who have heard of methods (Matlab) (Continued)
Attributes Pills Injectables Implants IUD Condoms Female sterilisation
Mean net positive score (2) 61.9 36.2 24.5 23.6 45.8 31.8
Mean % of don’t know (3) 4.9 11.2 36.7 36.4 26.0 35.4
TOTAL(N) 2600 2583 2253 1917 2572 2544
(1) Amongst those knowing some friends were using the methods
(2) Mean percent difference between percentages of women who gave positive and negative responses among the above attributes except husband’s approval
(3) Mean percent of women who said “don’t know” to the above attributes except experiences of a method in social network and husband’s approval
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Table 3 Percentage of women with specific opinions by use status (Matlab)
Attributes Pills Injectables Implants
Current users Past users Never users Current users Past users Never users Current users Past users Never users
Access
Easy 98.6 98.3 92.4 98.5 95.5 84.0 96.5 87.5 64.7
Hard 1.4 1.5 5.0 1.5 4.2 13.0 1.8 12.5 25.8
Don’t know/unsure 0.0 0.2 2.6 0.0 0.3 3.0 1.7 0.0 9.5
Effectiveness
Yes 99.8 99.4 98.5 98.9 99.1 98.1 100.0 96.4 96.9
No 0.2 0.6 0.6 1.1 0.8 1.1 0.0 3.6 0.5
Don’t know 0.0 0.0 0.9 0.0 0.1 0.8 0.0 0.0 2.6
Cause health problems
Yes, serious 0.9 3.8 3.3 2.2 11.0 6.7 1.8 28.6 8.0
Yes, not serious 10.6 23.6 24.7 22.6 43.3 29.5 24.6 35.7 14.5
No 88.5 72.4 36.6 75.3 45.5 23.6 71.9 28.6 9.0
Don’t know 0.0 0.2 35.4 0.0 0.2 40.2 1.7 7.1 68.5
Interfere with menstruation
Yes 6.0 9.0 5.8 67.9 72.2 41.8 43.9 53.6 14.0
No 93.8 90.6 56.6 31.0 27.5 14.0 52.6 39.3 11.1
Don’t know 0.2 0.4 37.6 1.1 0.3 44.2 3.5 7.1 74.9
Cause unpleasant side effect
Yes 14.1 31.9 26.5 26.3 52.3 31.8 29.8 57.1 17.4
No 85.8 67.7 37.9 73.3 47.3 26.0 66.7 37.5 10.1
Don’t know 0.2 0.4 36.6 0.4 0.4 42.2 3.5 5.4 72.5
Unsafe to use for a long time
Yes, should take a break 18.9 24.7 14.8 24.5 27.0 20.5 36.8 37.5 19.4
No, safe for long time 79.8 73.4 69.9 74.4 72.1 60.9 61.4 53.6 52.5
Don’t know 1.3 1.9 15.2 1.1 0.9 18.6 1.8 8.9 28.1
Cause infertility
Yes, perhaps 6.5 10.3 7.6 6.1 7.1 6.2 3.5 0.0 4.3
No 90.9 85.9 76.6 91.8 89.9 78.6 87.7 91.1 74.0
Don’t know 2.6 3.8 15.8 2.1 3.0 15.2 8.8 8.9 21.7
FP use among friends, relatives
Most 32.5 24.2 18.0 27.8 20.3 10.7 1.8 1.8 0.7
About half 15.0 10.5 11.3 18.0 14.7 13.8 7.0 5.3 1.1
Few 48.8 56.1 55.8 47.9 54.3 52.3 71.9 67.9 39.7
None 1.8 5.0 5.2 3.0 6.2 11.6 8.8 21.4 28.8
Don’t know 1.9 4.2 9.7 3.3 4.5 11.6 10.5 3.6 29.7
Experiences of friends, relatives (1)
Satisfactory 98.4 95.3 92.4 95.8 88.8 87.3 93.5 71.4 76.6
Unsatisfactory 0.5 3.5 1.3 2.6 9.7 3.7 4.3 21.4 8.2
Mixed/Don’t know 1.1 1.3 6.3 1.6 1.5 9.0 2.2 7.1 15.1
Husband’s approval
Approve 98.8 94.9 63.8 97.6 88.9 48.9 96.5 67.9 16.6
Disapprove 1.2 4.6 22.7 2.4 10.6 38.6 3.5 25.0 66.8
Don’t know 0.0 0.5 13.5 0.0 0.5 12.5 0.0 7.1 16.6
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databases in the Matlab and Nairobi sites. In Homa
Bay two-stage cluster sampling was used. A total of
34,308 women were identified as being married and
aged between 15 and 39 years in the Matlab HDSS
database. Out of these, 3109 were randomly selected
and 2605 women completed the interviews. The
Nairobi HDSS database identified a total of 5905 mar-
ried or cohabiting women who were eligible for inclu-
sion. Out of these, 3093 women were randomly
sampled and interviews were completed with 2812 of
the eligible women.
In Homa-Bay, we randomly selected 12 sub-locations
(the smallest administrative unit in Kenya) in each three
purposely identified sub-counties in Homa Bay County.
All households with currently married or co-habiting
women aged 15–49 years in the selected sub-locations
were identified with the help of the local administration.
Subsequently, the sampling frame was generated by list-
ing all individuals in these households. In the second
stage, 3118 were randomly sampled out of 5424 eligible
women. A total of 2424 women completed the
interviews.
All respondents provided written consents after hav-
ing been informed about the objectives, procedures,
benefits and risks of the study using an information
sheet and informed consent form. All married and
co-habiting adolescents aged 15–17 years were con-
sidered emancipated minors for whom parental per-
mission is not required.
The questionnaire was developed through literature
review and consultation with experts. We reviewed
existing literature and more than 30 questionnaires on
fertility preferences and reasons for non-use of family
planning fielded in high-, middle- and low-income coun-
tries including instruments from the DHS, the Determi-
nants of Unintended Pregnancy Risk study in New
Orleans; the US- based National Survey of Family
Growth (NSFG); and the Fog Zone study by the Guttma-
cher Institute. A questionnaire was developed and
reviewed through consultation with dozens of experts in
the field. The questionnaire was further refined after
pre-testing.
Structured interviews, lasting on average for
45–60 min, were conducted using the local languages
following a 7 to 10-day training. Very similar question-
naires were used in all three sites covering the following
topics: background, reproduction, contraceptive know-
ledge and use, beliefs and attitudes towards contracep-
tion in general and specific methods and fertility
preferences of the women. Two summary measures of
method-specific beliefs were generated. A net positive
score is the mean percent difference between positive
and negative responses across nine women’s attributes,
ignoring “don’t know” and perceived husband’s approval.
Positive responses refer to perceptions that a method is
easy to obtain and to use, very effective in preventing
pregnancy and safe to use for a long time without a
break, does not cause health problems, unpleasant side
effects, menstrual disruption or infertility, and that half
or more of friends, relatives, neighbours (i.e. social
network) had used the method and their experiences
were satisfactory. A familiarity measure which is simply
the mean percent responding “don’t know” across eight
attributes excluding experiences of method use among
women’s social network and perceived husband’s approval.
In addition, past and current users of a method were
asked whether they were satisfied or dissatisfied with use.
Descriptive analysis and chi-square tests were car-
ried out to assess differences in beliefs and attitudes
among current, past and never users of pills, inject-
ables and implants. Clustering was taken into account
for the statistical analyses when analysing the data
from Homa-Bay. We used STATA SE version 15.0 for
the data analysis.
Table 3 Percentage of women with specific opinions by use status (Matlab) (Continued)
Attributes Pills Injectables Implants
Current users Past users Never users Current users Past users Never users Current users Past users Never users
Satisfied with use
Satisfied 92.2 69.7 – 91.3 51.1 – 87.7 39.3 –
Unsatisfied 4.8 27.7 – 8.0 47.2 – 10.5 51.8 –
Mixed/Neither 3.0 2.6 – 0.7 1.7 – 1.8 8.9 –
Mean net positive score (2) 74.8 60.9 48.8 53.3 34.7 31.0 45.8 19.2 24.0
Mean % of don’t know (3) 0.8 1.4 19.2 1.0 1.2 22.0 3.9 5.1 38.4
TOTAL(N) 662 1399 539 461 877 1245 57 56 2140
(1) Amongst those knowing some friends were using the methods
(2) Mean percent difference between percentages of women who gave positive and negative responses among the above attributes except husband’s approval
(3) Mean percent of women who said "don’t know" to the above attributes except experiences of a method in social network and husband’s approval
Note: Chi-square test was conducted to assess associations between each of the above attributes and use status. The p-values were all 0.01 or smaller except the
perceptions on effectiveness of injectables (p = 0.067)
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Table 4 Percentage of women with specific opinions, amongst those who have heard of methods (Nairobi)
Attributes Pills Injectables Implants IUD Condoms Female sterilisation
Access
Easy 92.3 96.7 89.7 70.0 88.3 41.8
Hard 7.4 3.1 10.0 28.7 11.0 56.7
Don’t know/unsure 0.4 0.2 0.3 1.3 0.7 1.4
Effectiveness
Yes 69.8 89.1 89.2 70.0 61.1 68.4
No 29.9 10.8 10.5 28.1 38.1 31.1
Don’t know 0.3 0.1 0.3 1.8 0.8 0.5
Cause health problems
Yes, serious 12.5 18.5 23.2 35.4 4.0 30.0
Yes, not serious 28.8 37.1 36.2 24.6 11.6 13.5
No 58.2 44.2 40.1 38.1 83.4 54.2
Don’t know 0.6 0.2 0.5 1.9 1.1 2.3
Interfere with menstruation
Yes 40.5 78.0 66.5 48.9 – 30.3
No 58.5 21.5 32.6 47.3 – 63.8
Don’t know 1.0 0.5 0.9 3.8 – 5.9
Cause unpleasant side effect
Yes 47.2 59.9 58.7 58.7 18.0 40.6
No 52.4 40.0 41.0 39.7 81.2 56.5
Don’t know 0.5 0.1 0.3 1.5 0.8 2.9
Unsafe to use for a long time
Yes, should take a break 70.1 62.9 56.9 65.2 48.8 –
No, safe for long time 29.5 36.7 42.7 33.3 49.6 –
Don’t know 0.4 0.4 0.4 1.5 1.6 –
Cause infertility
Yes, perhaps 13.8 28.0 21.8 18.9 – –
No 85.6 71.6 77.4 79.2 – –
Don’t know 0.5 0.4 0.8 1.9 – –
FP use among friends, relatives
Most 20.2 63.5 38.2 5.7 11.4 1.7
About half 7.1 9.9 13.7 2.9 2.4 0.6
Few 52.2 21.1 39.3 49.4 28.2 32.5
None 19.7 4.8 8.3 40.9 54.8 64.5
Don’t know 0.7 0.7 0.5 1.0 3.1 0.7
Experiences of friends, relatives (1)
Satisfactory 55.1 60.2 59 50.7 70.6 71.1
Unsatisfactory 24.3 14.8 19.2 30.1 15.2 20.5
Mixed/Don’t know 20.6 25 21.9 19.2 14.3 8.3
Husband’s approval
Approve 63.6 77.4 62.6 30.6 29.4 14.0
Disapprove 35.9 22.1 36.5 68.0 70.0 84.9
Don’t know 0.5 0.5 0.8 1.4 0.6 1.1
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Ethical approvals for this study were obtained from
the Institutional Review Boards of the countries and
three participating institutions.
Results
The number of women successfully interviewed was
2424 in Homa Bay, 2605 in Matlab, and 2812 in Nairobi
(Additional file 1: Table S1). The average ages of women
in the three sites were closely similar, 28 or 29 years
(Table 1). About 70% in Matlab had secondary or higher
schooling, compared with 40% in Nairobi and 23% in
Homa Bay. The mean number of surviving children was
lowest in Matlab, highest in Homa Bay and intermediate
in Nairobi. Women in Matlab were much more likely to
express a desire to stop childbearing than those in the
Kenyan sites. In Nairobi, 75% were currently using a
method of contraception, with injectables followed by
implants, as the dominant methods. In Homa Bay, the
level of current use was 65%, with a method-mix similar
to that in Nairobi. Current use was lowest in Matlab
(59%), where oral contraception pills and injectables
were the favoured methods. But this unexpected result,
in view of the far lower fertility rate in Matlab, may
largely reflect the fact that 34% of husbands had been
away for three months or longer preceding the date of
interview, mainly as migrant workers, thus reducing the
need for pregnancy-protection.
Generic attitudes
Though the focus of this paper is on method-specific be-
liefs, we start by presenting information on attitudes to-
wards contraceptive use in general. In all three sites,
over 90% of women reported that they supported family
planning, but 25% in Homa Bay and 12% in Nairobi per-
ceived their husbands to be opposed (Additional file 1:
Table S2). Use of contraception by women’s social net-
work of friends, neighbours, and relatives was thought
to be common and their attitudes were favourable in all
three sites. Conversely, only around half in Matlab (51%)
and Homa Bay (47%) and three-fourths (76%) in Nairobi
perceived that their religion supports family planning.
Large majorities considered the following features of
methods to be very important: effectiveness, no health
risk, lack of unpleasant side effects, no effect on
menstruation, and ease of access and use (Additional
file 1: Table S3). The amenability of a method for
clandestine use and use for a long time without the
need for re-supply were endorsed as very important
by smaller majorities.
Method-specific beliefs and opinions: Matlab
A total of ten opinions and beliefs was ascertained for all
women who have ever heard of each of six modern
methods (Tables 2, 3, 4, 5, 6 and 7) and two traditional
methods (Additional file 1: Table S4). Because of the
wide array of information, the discussion here will be
highly selective.
In Matlab, implants, IUDs and female sterilisation
were rarely used and unfamiliarity was reflected in the
high proportions of respondents who said “don’t know”
on attributes of these methods. Thus over half of women
did not know whether these methods might cause health
problems, unpleasant side effects or menstrual disrup-
tion. However, nearly all women acknowledged these
three methods to be effective and two-thirds or more
thought access would be easy. Among those knowing so-
cial network members who had used these methods,
over three-quarters deemed their experience to be satis-
factory. Yet a majority considered that their husband
would disapprove of using these methods.
Oral contraceptives followed by injectables dominate
the method-mix. Pills attracted more favourable opin-
ions than injectables. For instance, 40% and 38% thought
injectables might cause health problems and unpleasant
side effects, respectively, compared with 24% and 26%
for pills. Nearly one-quarter thought that their husbands
would disapprove of their use of injectables compared
with 8% for pills. The two methods were rated similarly
on other dimensions. Both were regarded as easy to ob-
tain and effective. The experience of their social network
with use of either method was judged to be satisfactory
by over 90%. Very few thought that either method might
cause infertility and almost equal proportions considered
long term use to be safe.
We compared the views of current, past and never
users of pills, injectables and implants (Table 3). The lar-
gest consistent difference between current and past users
across all three methods was the view that the method
Table 4 Percentage of women with specific opinions, amongst those who have heard of methods (Nairobi) (Continued)
Attributes Pills Injectables Implants IUD Condoms Female sterilisation
Mean net positive score (2) 20.3 21.6 19.2 0.9 31.2 5.5
Mean % of don’t know (3) 0.5 0.3 0.5 1.9 1.4 2.3
TOTAL (N) 2787 2808 2789 2664 2792 2423
(1) Amongst those knowing some friends were using the methods
(2) Mean percent difference between percentages of women who gave positive and negative responses among the above attributes except husband’s approval
(3) Mean percent of women who said 'don’t know' to the above attributes except experiences of a method in social network and husband’s approval
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Table 5 Percentage of women with specific opinions by use status (Nairobi)
Attributes Pills Injectables Implants
Current users Past users Never users Current users Past users Never users Current users Past users Never users
Access
Easy 98.3 94.0 90.6 99.1 96.9 93.0 96.7 92.4 87.1
Hard 1.7 6.0 8.8 0.9 3.0 6.3 3.3 7.6 12.5
Don’t know/unsure 0.0 0.0 0.6 0.0 0.1 0.7 0.0 0.0 0.4
Effectiveness
Yes 93.6 70.9 65.9 97.7 86.0 83.4 98.2 89.0 86.6
No 6.4 29.0 33.7 2.3 14.0 16.2 1.8 11.0 12.9
Don’t know 0.0 0.1 0.4 0.0 0.0 0.4 0.0 0.0 0.4
Cause health problems
Yes, serious 5.1 14.2 12.6 10.6 23.0 21.1 9.7 35.5 24.5
Yes, not serious 18.4 32.7 28.2 33.4 38.5 39.4 31.9 35.9 37.6
No 76.5 52.9 58.4 55.9 38.5 38.9 58.5 28.4 37.2
Don’t know 0.0 0.2 0.8 0.1 0.0 0.6 0.0 0.2 0.7
Interfere with menstruation
Yes 25.2 40.7 42.5 73.0 82.3 77.1 59.6 75.1 66.7
No 74.8 59.0 55.9 27.0 17.7 21.0 40.4 24.9 31.9
Don’t know 0.0 0.2 1.6 0.0 0.0 1.9 0.0 0.0 1.4
Cause unpleasant side effect
Yes 30.3 51.4 47.3 50.6 65.8 61.7 44.8 70.9 60.1
No 69.7 48.6 51.9 49.4 34.2 37.9 55.2 28.9 39.5
Don’t know 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.2 0.4
Unsafe to use for a long time
Yes, should take a break 46.2 69.2 74.0 49.0 70.0 69.0 37.9 61.6 61.6
No, safe for long use 53.8 30.8 25.4 50.9 29.9 29.8 61.9 38.4 37.9
Don’t know 0.0 0.0 0.7 0.1 0.2 1.2 0.2 0.0 0.5
Cause infertility
Yes, perhaps 9.8 13.1 14.7 26.1 30.0 26.9 16.0 22.7 23.4
No 89.3 86.8 84.6 73.6 69.8 72.1 83.4 77.0 75.7
Don’t know 0.9 0.1 0.7 0.3 0.2 1.0 0.5 0.2 0.9
FP use among friends, relatives
Most 34.2 26.1 15.3 72.6 63.0 52.1 56.3 46.9 30.8
About half 10.7 7.5 6.5 9.2 10.0 10.7 14.9 14.7 13.1
Few 45.3 50.6 54.0 15.2 22.3 26.9 25.9 33.0 44.7
None 9.8 15.2 23.5 2.5 4.2 9.0 2.7 4.6 10.8
Don’t know 0.0 0.6 0.8 0.4 0.5 1.3 0.2 0.7 0.6
Experiences of friends, relatives (1)
Satisfactory 83.4 52 52.2 74.9 52.9 52.7 75.2 48.8 56
Unsatisfactory 5.2 27.9 25.3 4.6 19.3 20.9 6.6 25.1 21.9
Mixed/Don’t know 11.4 20.1 22.4 20.4 27.8 26.4 18.2 26.1 22.1
Husband’s approval
Approve 92.3 71.8 55.3 91.5 77.5 58.4 90.0 68.5 53.1
Disapprove 7.69 28.19 43.82 8.4 22.4 39.8 9.8 31.5 45.7
Don’t know 0.0 0.0 0.8 0.1 0.1 1.8 0.2 0.0 1.2
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caused unpleasant side effects, though appreciable mi-
norities (from 14% for the pill to 30% for the implant) of
current users acknowledged side effects. Notably, 29% of
past implant users thought that the method caused ser-
ious health problems. Furthermore, past implant users
were more likely to rate their experience as unsatisfac-
tory than past injectable or pill users.
Method-specific beliefs and opinions: Nairobi
As indicated by the mean net positive scores, beliefs
about methods were less favourable in Nairobi than in
Matlab and the proportions giving “don’t know” re-
sponses were much lower. With the exception of steril-
isation, large majorities considered methods easy to
obtain (Table 4). Injectables and implants were judged to
be effective by 90%. However, in a clear departure from
objective evidence, this level falls to about 70% for IUDs
and sterilisation. The view that a method might cause
serious health problems was widespread (with the excep-
tion of condoms), rising from 13% for pills to 30% for
sterilisation and 35% for IUDs. Similarly, about 60% as-
sociated injectables, implants, and IUDs with unpleasant
side effects, as did over 40% for pills and sterilisation.
Only minorities were of the view that the hormonal
methods and IUDs could be safely used for a long time
without taking a break. Between 14% (pills) and 28% (in-
jectables) of women thought that a method might cause
infertility. Despite these views, between 51% and 71%
rated the experience of social network members with
use of methods as satisfactory. While most women
thought that their partners would approve of their use of
pills, injectables and implants, perceived approval
dropped to 30% for IUDs and condoms and further to
14% for sterilisation.
Analysis of opinions by use status showed sharp di-
vides between current users and past or never users
(Table 5). For instance, 11% of current injectable
users (the dominant method in this site) believed that
the method caused serious health problems compared
with over 20% of past or never users. This difference
was more pronounced for implants: 10% for current
users versus 36% for past users and 25% for never
users. Similarly, about three quarters of current users
of injectables, pills and implants reported satisfactory
experience of their social network compared with
about 50% of past and never users. A clear gradient
in perceived partner’s approval is apparent for all
three methods, with 90% approval for current users,
around 70% for past users and 50–60% for never
users. Nevertheless, appreciable proportions of current
users held negative views about their method: 30%,
51% and 45% of pill, injectable and implant users, re-
spectively, thought that the method caused unpleasant
side effects. Around 40% of current users considered
their method to be unsafe for prolonged use. Despite
these reservations, close to 90% of current users rated
their method as satisfactory compared with 32–44%
of past users.
Method-specific beliefs and opinions: Homa Bay
Condoms received a much higher mean net positive score
than other methods and perceived partner’s approval of
this method was higher in this site with high adult HIV
prevalence than in Matlab or Nairobi. The experience of
social network members with use of condoms was more
likely to be rated as satisfactory than other methods: 73%
for condoms compared with 54–58% for the two
dominant methods, injectables and implants (Table 6).
Condoms were more likely to be considered as effect-
ive than pills, though less likely than injectables and
implants.
With the exception of condoms, about 30% thought
that other methods caused serious health problems; be-
tween 38% (sterilisation) and 63% (injectables)
Table 5 Percentage of women with specific opinions by use status (Nairobi) (Continued)
Attributes Pills Injectables Implants
Current users Past users Never users Current users Past users Never users Current users Past users Never users
Satisfied with use
Satisfied 90.2 41.3 – 87.7 44.9 – 86.5 32.3 –
Unsatisfied 8.5 55.8 – 10.5 53.2 – 10.7 64.8 –
Mixed/Neither 1.3 2.3 – 1.3 1.3 – 2.0 2.0 –
Missing 0.0 0.6 – 0.6 0.6 – 0.7 1.0 –
Mean net positive score (2) 53.4 19.8 15.8 38.0 14.1 13.0 44.5 11.8 13.2
Mean % of don’t know (3) 0.1 0.2 0.8 0.1 0.1 1.0 0.1 0.2 0.7
TOTAL(N) 234 869 1684 909 1218 681 549 409 1831
(1) Amongst those knowing some friends were using the methods
(2) Mean percent difference between percentages of women who gave positive and negative responses among the above attributes except husband’s approval
(3) Mean percent of women who said "don’t know" to the above attributes except experiences of a method in social network and husband’s approval
Note: Chi-square test was conducted to assess associations between each of the above attributes and use status. The p-values were all 0.01 or smaller except the
perceptions on risk of infertility of pills (p = 0.061) and injectables (p = 0.015)
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Table 6 Percentage of women with specific opinions, amongst those who have heard of methods (Homa Bay)
Attributes Pills Injectables Implants IUD Condoms (4) Female sterilisation (5)
Access
Easy 79.4 90.4 84.5 52.8 93.9 41.7
Hard 12.5 7.9 10.5 25.8 3.6 40.3
Don’t know/unsure 8.1 1.6 5.0 21.4 2.5 18.0
Effectiveness
Yes 62.6 91.6 90.3 66.1 77.5 82.5
No 23.8 5.6 3.7 8.6 17.4 5.4
Don’t know 13.5 2.8 6.0 25.3 5.1 12.1
Cause health problems
Yes, serious 37.8 31.2 28.3 36.0 11.4 32.7
Yes, not serious 21.5 31.0 25.9 16.0 11.3 12.2
No 23.0 30.1 30.5 18.7 70.0 31.5
Don’t know 17.7 7.7 15.4 29.3 7.3 23.6
Interfere with menstruation
Yes 56.5 80.2 60.1 35.6 – –
No 22.1 14.7 22.5 25.1 – –
Don’t know 21.4 5.2 17.4 39.2 – –
Cause unpleasant side effect
Yes 57.5 63.2 51.7 44.7 14.0 38.3
No 21.6 28.7 30.1 20.9 77.6 36.0
Don’t know 20.9 8.2 18.2 34.4 8.4 25.7
Unsafe to use for a long time
Yes, should take a break 66.9 68.5 60.8 62.5 37.3 –
No, safe for long time 20.3 26.3 31.7 17.4 56.4 –
Don’t know 12.8 5.2 7.6 20.0 6.3 –
Cause infertility
Yes, perhaps 15.6 17.1 12.7 16.2 – –
No 72.9 77.3 78.1 63.4 – –
Don’t know 11.6 5.7 9.2 20.5 – –
FP use among friends, relatives
Most 13.9 64.6 49.1 3.9 30.3 3.3
About half 7.4 8.3 8.7 3.5 7.7 2.7
Few 49.3 19.0 31.8 42.4 26.0 51.3
None 13.8 2.1 3.7 26.9 6.1 26.0
Don’t know 15.7 6.0 6.8 23.4 30.0 16.7
Experiences of friends, relatives (1)
Satisfactory 38.0 54.1 57.7 39.4 72.9 59.1
Unsatisfactory 28.5 11.2 13.1 27.2 10.6 17.3
Mixed/Don’t know 33.5 34.7 29.2 33.4 16.5 17.1
Husband disapprove
Approve 45.5 64.4 52.2 25.2 53.3 18.1
Disapprove 43.7 30.2 38.7 58.8 41.2 70.5
Don’t know 10.8 5.5 9.1 15.9 5.5 11.4
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considered that methods caused unpleasant side effects
and about two-thirds judged methods to be unsafe for
prolonged use without taking a break.
As in Nairobi, current users of pills, injectables and
implants were much more likely to express positive
views about their method than past or never users,
except with regard to fears among a minority of
women about infertility. However, the prevalence of
adverse views even among current users was striking.
Thus, 14%, 24% and 16% of current pill, injectable
and implant users, respectively, considered that their
method caused serious health problems and between
34% and 55% associated the method with unpleasant
side effects. These adverse beliefs did not translate
into dissatisfaction with the current method: on the
contrary, between 77% and 88% judged their method
to be satisfactory while only 31–45% of past users
were satisfied with the use.
Discussion
In view of the principle of cognitive dissonance—the
tendency to align beliefs and attitudes to behaviour—it is
no surprise that most current users of a method con-
sider it to be satisfactory and express more positive
views than past or never users. In apparent contradiction
to high overall satisfaction is the finding that appreciable
proportions of these current users appear to be con-
cerned about serious health effects and acknowledge
that the method causes unpleasant side effects. The view
that it is unsafe to use a method for a long time without
taking a break is widespread among current users, par-
ticularly in the Kenyan sites. Follow-up surveys will es-
tablish the impact of these perceptions on
discontinuation.
Dissatisfaction among past users, who tend to out-
number current users, may be a powerful influence
on the overall climate of opinion; indeed the views of
past and never users tend to be similar. The low level
of overall satisfaction among past users of injectables,
pills and implants in Kenyan sites, associated with
health worries and side effects, is a concern, particu-
larly with implant users of whom only about 30% in
Nairobi reported satisfaction. A continuation of the
steep rise in the use of implants in Kenya, therefore,
could be in jeopardy. Similarly in Matlab, the results
imply considerable potential resistance to long-acting
reversible methods (IUDs and implants), the promo-
tion of which is a national priority.
The study is not without limitations. Information on
perceived partner’s approval of specific methods is diffi-
cult to interpret. While close to 90% reported partner’s
support of family planning in general, perceived approval
is low in Matlab for use of implants, IUDs and female
sterilisation, and also low in the Kenyan sites for use of
IUDs and sterilisation. Whether or not, these results re-
flect women’s own misgivings about these methods re-
mains unclear.
The value of this detailed information in explaining
reproductive and contraceptive behaviour is uncertain
and a verdict must await the results of follow-up sur-
veys. Nevertheless, the results are of considerable
interest because this study, to our knowledge, is the
first to have obtained comparable quantitative infor-
mation in LMICs on attitudes and beliefs on each of
eight major family planning methods. Many of the
findings from this study are consistent with earlier
studies that have documented fears about side effects
and damage to health to be widespread. The result
regarding the belief that it is unsafe to use a method
for a long term without taking a break is simiar to
the common behaviours observed in the Philippines
[28]. Other findings are new and have considerable
possible implications for behaviour.
Moreover, the ability of this study to contrast the be-
liefs of current, past and never users of the three more
prevalent methods represents a major contribution. In
2015 an expert meeting on misperceptions about contra-
ceptives called for a revitalization of discussion on this
issue. Participants identified the need for quantitative
data that distinguish concerns stemming from docu-
mented side effects from those resulting from rumours
or myths and the need for evidence about links between
misperceptions and method choice [29]. This paper
starts to address these gaps in evidence and further pro-
gress is expected when follow-up survey data become
available.
Table 6 Percentage of women with specific opinions, amongst those who have heard of methods (Homa Bay) (Continued)
Attributes Pills Injectables Implants IUD Condoms (4) Female sterilisation (5)
Mean net positive score (2) −2.5 16.6 20.1 −3.4 49.8 5.6
Mean % of don’t know (3) 15.2 5.3 10.7 26.7 9.9 19.2
TOTAL(N) 2358 2405 2391 1973 1338 2080
(1) Amongst those knowing some friends were using the methods
(2) Mean percent difference between percentages of women who gave positive and negative responses among the above attributes except husband’s approval
(3) Mean percent of women who said “don’t know” to the above attributes except experiences of a method in social network and husband’s approval
(4) 1008 responses missing owing to error in electronic data capture program
(5) The question on interference with menstruation was not asked for female sterilisation in Homa-Bay
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Table 7 Percentage of women with specific opinions by use status (Homa Bay)
Attributes Pills Injectables Implants
Current users Past users Never users Current users Past users Never users Current users Past users Never users
Access
Easy 92.3 84.7 77.1 93.7 90.6 87.0 93.9 88.7 81.1
Hard 7.7 12.5 12.7 6.2 8.7 8.4 6.2 8.3 12.1
Don’t know/unsure 0.0 2.8 10.3 0.2 0.7 4.6 0.0 3.0 6.9
Effectiveness
Yes 86.2 66.8 60.3 97.1 92.1 85.2 98.6 89.9 88.1
No 10.8 28.5 22.8 2.1 7.0 6.8 1.1 5.7 4.0
Don’t know 3.1 4.7 16.9 0.8 0.8 8.0 0.2 4.5 7.9
Cause health problems
Yes, serious 13.9 42.7 37.0 24.2 36.8 29.4 16.4 36.3 29.9
Yes, not serious 33.9 22.9 20.6 30.1 32.3 30.0 24.6 26.2 26.1
No 46.2 26.2 21.0 40.9 27.7 23.3 51.5 31.9 24.4
Don’t know 6.2 8.2 21.4 4.8 3.3 17.3 7.5 5.7 19.6
Interfere with menstruation
Yes 40.0 59.6 56.1 80.2 84.1 74.0 62.9 67.9 57.6
No 53.9 32.5 17.4 19.0 14.2 11.2 35.3 24.4 18.7
Don’t know 6.2 8.0 26.5 0.8 1.8 14.8 1.8 7.7 23.7
Cause unpleasant side effect
Yes 33.9 63.0 56.5 55.3 68.7 62.2 41.0 59.8 53.0
No 60.0 29.0 17.7 39.9 27.8 19.2 51.7 31.9 23.9
Don’t know 6.2 8.0 25.8 4.8 3.6 18.6 7.3 8.3 23.1
Unsafe to use for a long time
Yes, should take a break 47.7 70.5 66.4 58.0 73.7 70.6 50.8 65.2 62.6
No, safe for long time 40.0 22.4 18.9 37.3 23.6 19.9 47.2 29.8 27.9
Don’t Know 12.3 7.1 14.7 4.7 2.7 9.5 2.1 5.1 9.6
Cause infertility
Yes, perhaps 15.4 15.6 15.6 15.4 16.8 19.3 10.7 13.4 13.1
No 80.0 77.4 71.1 80.5 80.0 69.8 83.4 81.0 76.1
Don’t know 4.6 6.9 13.4 4.1 3.2 11.0 5.9 5.7 10.8
FP use among friends, relatives
Most 18.5 19.1 11.9 73.6 66.7 52.6 70.8 53.9 42.1
About half 10.8 8.0 7.1 6.8 7.7 10.6 6.6 6.6 9.7
Few 50.8 45.1 50.6 14.7 17.6 25.3 18.2 30.4 35.7
None 7.7 13.4 14.2 0.9 2.4 2.8 1.8 2.7 4.5
Don’t know 12.3 14.4 16.2 4.1 5.5 8.7 2.5 6.6 8.0
Experiences of friends, relatives (1)
Satisfactory 65.4 39.7 36.2 69.0 48.2 47.9 77.6 49.2 53.6
Unsatisfactory 11.5 34.9 27.0 4.0 15.4 11.7 3.8 21.6 14.1
Mixed/Don’t know 23.1 25.5 36.7 27.0 36.4 40.4 18.6 29.2 32.3
Husband’s approval
Approve 76.9 55.6 40.9 77.2 67.5 47.0 77.7 59.8 43.7
Disapprove 20.0 38.4 46.4 20.7 29.1 41.1 20.7 36.0 44.2
Don’t know 3.1 6.1 12.6 2.1 3.4 12.0 1.6 4.2 12.1
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Conclusions
In conclusion, high levels of contraceptive use can clearly
co-exist with widespread misgivings about methods, even
those that are widely used. Serious concerns about damage
to health, long term fertility impairment, and dangers of
prolonged use without taking a break were particularly com-
mon in the Kenyan sites and these beliefs may explain the
high levels of discontinuation observed in Kenya and else-
where in Africa. This documentation of beliefs provides use-
ful guidance for counselling and informational campaigns.
The generally negative views of past users imply that pro-
grammes may need not only to improve individual counsel-
ling but also strengthen community information campaign
to change the overall climate of opinion which may have
been influenced by dissatisfaction among past users.
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